Progesterone receptor levels independently predict survival in endometrial adenocarcinoma.
about
Molecular pathogenesis and prognostic factors in endometrial carcinoma.A phase II evaluation of gefitinib in the treatment of persistent or recurrent endometrial cancer: a Gynecologic Oncology Group studyMultiple brain metastases in a patient with uterine papillary serous adenocarcinoma: Treatment options for this rarely seen metastatic brain tumor.The hormonal receptor status of uterine carcinosarcomas (mixed müllerian tumours): an immunohistochemical studyHormone Receptor Expression in Spontaneous Uterine Adenocarcinoma in Fischer 344 Rats.Clinicopathological and prognostic impact of human epidermal growth factor receptor type 2 (HER2) and hormone receptor expression in uterine papillary serous carcinoma.
P2860
Progesterone receptor levels independently predict survival in endometrial adenocarcinoma.
description
1995 nî lūn-bûn
@nan
1995年の論文
@ja
1995年論文
@yue
1995年論文
@zh-hant
1995年論文
@zh-hk
1995年論文
@zh-mo
1995年論文
@zh-tw
1995年论文
@wuu
1995年论文
@zh
1995年论文
@zh-cn
name
Progesterone receptor levels i ...... in endometrial adenocarcinoma.
@en
type
label
Progesterone receptor levels i ...... in endometrial adenocarcinoma.
@en
prefLabel
Progesterone receptor levels i ...... in endometrial adenocarcinoma.
@en
P2093
P356
P1433
P1476
Progesterone receptor levels i ...... in endometrial adenocarcinoma.
@en
P2093
Christensen IJ
Nielsen AL
P304
P356
10.1006/GYNO.1995.9964
P407
P577
1995-12-01T00:00:00Z